Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study (EMOREC)

July 23, 2025 updated by: Hôpital le Vinatier
This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Study Overview

Detailed Description

Sexual abuse is a major public health issue. Apart from medical care of victims, it appears essential to intervene with sexual offenders for prevention purposes (from primary prevention to avoid a first sexual abuse to secondary and tertiary prevention to avoid recurrence). In order to improve those prevention strategies, further understanding of offenders neuropsychological and cognitive processes is needed.

Facial emotion recognition capacities, that play a major role in social cognition and generation of appropriate social behavior, has been the subject of few studies in sexual offenders. These studies show heterogeneous results and only one of them specifically targets sexual offenders against children. Furthermore, no study has investigated facial emotion recognition in this population with an objective measurement of emotional processing, such as electroencephalographic (EEG) activity. LPP (late positive potential) amplitude, measured in EEG, is a marker of emotional processing and appears to be modified in particular populations (eg. psychopaths) in response to negative visual stimuli compared to positive stimuli.

The investigators aim to determine whether LPP amplitude in response to negative facial expressions is modified in sexual offenders against children compared to healthy volunteers and compared to amplitude in response to positive facial expressions.

Effect of facial emotion characteristics (type of emotion, age and sex of person expressing the emotion) on EEG response will be assessed.

Various neuropsychological and cognitive characteristics (facial emotion recognition, theory of mind, psychopathic traits, childhood trauma, and alexithymia) of patients and controls will also be measured through neuropsychological evaluation and completion of scales and questionnaires, in order to investigate the impact of those factors on facial emotion recognition performances.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhône Alpes
      • Bron, Rhône Alpes, France, 69678
        • Centre Hospitalier Le Vinatier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria SUBJECTS - Sexual offenders against children:

  • Right-handed ;
  • Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ;
  • Without any Axis 1 disorder ;
  • Having given informed consent ;
  • Affiliated to French social health care

Exclusion Criteria:

  • Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders);
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure

Healthy controls :

Inclusion Criteria:

  • Right-handed ;
  • Without criminal background ;
  • Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
  • Non-caregiver employee of Le Vinatier Hospital Center.

Exclusion Criteria:

  • Intellectual disability (using fNART if clinical suspicion during run-in period);
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy controls

2. RUN-IN PERIOD :

  • Eligibility criteria will be assessed during the multidisciplinary meeting;
  • Study presentation, delivery of the information note and consent form; 3. STUDY:
  • Collection of consent form;
  • Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
  • Neuropsychological evaluation (TOM-15);
  • Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
  • Debriefing.
Other Names:
  • Neuropsychological evaluation
Experimental: Sexual offenders against children
sexual offenders against children
1. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient

2. RUN-IN PERIOD :

  • Eligibility criteria will be assessed during the multidisciplinary meeting;
  • Study presentation, delivery of the information note and consent form; 3. STUDY:
  • Collection of consent form;
  • Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
  • Neuropsychological evaluation (TOM-15);
  • Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
  • Debriefing.
Other Names:
  • Neuropsychological evaluation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amplitude of LPP during the facial emotion stimuli presentation task
Time Frame: one day

The facial emotion stimuli presentation task is based on pictures from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

During the task, cerebral activity will be recorded by EEG to measure amplitude and latency of the LPP (Late Positive Potential).

one day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Facial emotion recognition abilities
Time Frame: one day

Subjects and controls will be presented with facial emotion stimuli from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

We will measure recognition abilities (% correct response rate, response time, intensity and valence ratings).

one day
TOM-15 (Theory Of Mind 15)
Time Frame: one day
validated test for assessment of theory of mind
one day
TAS20 (Toronto Alexithymia Scale 20)
Time Frame: one day
validated scale for assessment of alexithymia Scores vary from 20/100 (low level of alexithymia) to 100/100 (high level of alexithymia)
one day
PCL-R SV (Psychopathy Checklist Revised - Short Version)
Time Frame: one day
validated checklist for assessment of psychopathy Scores vary from 0/24 (no psychopathic traits) to 24/24 (high level of psychopathic traits)
one day
QCAE (Questionnaire of Cognitive and Affective Empathy)
Time Frame: one day

validated questionnaire for assessment of cognitive and affective empathy Affective empathy scores vary from 12/48 (low level of affective empathy) to 48/48 (high level of affective empathy).

Cognitive empathy scores vary from 19/76 (low level of cognitive empathy) to 76/76 (high level of cognitive empathy).

Total empathy scores vary from 31/124 (low level of empathy) to 124/124 (high level of empathy).

one day
CECA-Q (Childhood Experiences of Care and Abuse - Questionnaire)
Time Frame: one day

validated questionnaire for assessment of childhood experience of care and abuse Global parental antipathy scores vary from 20/160 (low level of parental antipathy) to 160/160 (high level of parental antipathy).

Neglect scores vary from 20/160 (low level of neglect) to 160/160 (high level of neglect).

Physical abuses scores vary from 0/8 (no physical abuses) to 8/8 (high level of physical abuses during childhood) Scores of sexual abuse vary from 0 (no sexual abuse) à 7 (serious sexual abuse) Prevalence of psychological abuse vary from 0/34 (no psychological abuse) to 34/34 (multiple psychological abuses) Frequence of psychological abuse vary from 0/102 ( no psychological abuse) to 102/102 (frequent psychological abuse)

one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabine MOUCHET, PH, CH le vinatier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2022

Primary Completion (Actual)

May 15, 2025

Study Completion (Actual)

May 15, 2025

Study Registration Dates

First Submitted

April 20, 2022

First Submitted That Met QC Criteria

May 16, 2022

First Posted (Actual)

May 20, 2022

Study Record Updates

Last Update Posted (Actual)

July 24, 2025

Last Update Submitted That Met QC Criteria

July 23, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-A02763-38

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotion Recognition

Clinical Trials on ROUTINE CARE

Subscribe